CATALOGO DEI PRODOTTI DELLA RICERCA

CETTO, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.272
EU - Europa 4.708
AS - Asia 1.611
SA - Sud America 17
AF - Africa 8
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 11.627
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.259
GB - Regno Unito 1.561
CN - Cina 1.154
SE - Svezia 613
IT - Italia 508
IE - Irlanda 448
FR - Francia 439
FI - Finlandia 372
SG - Singapore 332
DE - Germania 284
RU - Federazione Russa 284
UA - Ucraina 101
BE - Belgio 36
IR - Iran 23
TR - Turchia 20
IL - Israele 17
JP - Giappone 17
IN - India 15
CA - Canada 10
NL - Olanda 10
CZ - Repubblica Ceca 8
BR - Brasile 7
CH - Svizzera 7
KR - Corea 7
LV - Lettonia 7
VN - Vietnam 6
AU - Australia 5
RO - Romania 5
EU - Europa 4
PT - Portogallo 4
AL - Albania 3
AT - Austria 3
CL - Cile 3
EG - Egitto 3
HK - Hong Kong 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
AR - Argentina 2
AZ - Azerbaigian 2
BD - Bangladesh 2
BG - Bulgaria 2
BO - Bolivia 2
DK - Danimarca 2
GR - Grecia 2
ID - Indonesia 2
KG - Kirghizistan 2
MA - Marocco 2
MX - Messico 2
NO - Norvegia 2
PE - Perù 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PK - Pakistan 1
TH - Thailandia 1
Totale 11.627
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.426
Southend 1.366
Chandler 811
Dublin 447
Woodbridge 446
Ashburn 301
Ann Arbor 297
Houston 294
Singapore 238
Lawrence 164
Princeton 164
Wilmington 154
Beijing 125
Nanjing 118
Jinan 112
New York 108
Shenyang 108
Hebei 90
Milan 70
Tianjin 61
Ningbo 52
Zhengzhou 52
Boardman 49
Haikou 44
Nanchang 44
Helsinki 42
Sindelfingen 41
Hangzhou 40
Changsha 39
Brussels 35
Taizhou 35
Verona 33
Jiaxing 31
Lancaster 27
Norwalk 25
Falls Church 23
Fairfield 22
Seattle 21
Taiyuan 21
Fuzhou 19
Rome 19
Guangzhou 17
Philadelphia 17
Los Angeles 15
Santa Clara 15
Lanzhou 13
Tokyo 13
Kent 12
Parma 12
Chicago 10
Dallas 10
Dearborn 9
Auburn Hills 8
London 8
Napoli 8
Redwood City 8
Cambridge 7
Moscow 7
Seoul 7
Toronto 7
Zanjan 7
Amsterdam 6
Clearwater 6
San Francisco 6
Washington 6
Düsseldorf 5
Kemerovo 5
Redmond 5
Riva 5
San Diego 5
Torino 5
Yicheng 5
Ardabil 4
Berlin 4
Bologna 4
Leawood 4
Patiāla 4
Prague 4
Riga 4
Bari 3
Cairo 3
Detroit 3
Forlì 3
Newark 3
Palermo 3
San Mateo 3
Stockholm 3
Tappahannock 3
Windsor 3
Ypsilanti 3
Zurich 3
Andover 2
Athens 2
Atri 2
Augusta 2
Baku 2
Bishkek 2
Boston 2
Bratislava 2
Brno 2
Totale 7.965
Salva come PNG Salva come JPEG
Nome #
Il Formestone (4-Idrossiandrostenedione-LentaronR) nel trattamento di pazienti con cr. mammario metastatico. 245
Significato prognostico dell'indice di proliferazione cellulare nel carcinoma mammario. 166
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 123
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 120
Gamma Knife radiosurgery in brain metastases from testicular tumors 120
Pseudomonas septicaemia. A review of 60 cases observed in a university hospital 118
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer 112
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 110
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 110
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 109
Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis. 109
Current trends in hematopoietic stem cell transplantation in Europe 107
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 107
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 105
bcl-2 but not p53 expression is associated with resistance to chemotherapy in advanced breast cancer 105
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 104
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 103
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 103
Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods 101
Terminal transferase expression in relapsed acute myeloid leukaemia 101
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 100
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 99
Estrogen receptors in 699 primary breast cancers: a comparison of immunohistochemical and biochemical methods. 98
Cisplatin pharmacokinetics in elderly patients 97
Virtual colonoscopy in the surveillance of suspected HNPCC carriers: a preliminary study 97
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 97
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 97
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 96
Gram-negative septicemia in patients with hematologic malignancies 96
Pathological,biological and clinical characteristics and surgical mamagement of ederly women with brest cancer 95
A feasibility study for an hospital-based breast cancer registry. 95
Comportamento dell'ACE e del CEA in pazienti affetti da carcinoma polmonare. 94
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 93
Establishment and characterization of a new human melanoma cell line (HU 214) with a high growth potential and stable properties 92
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 91
Cation content and membrane deformability of heterozygous beta-thalassaemic red blood cells 91
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 91
Analisi di linkage in famiglie con carcinoma mammario ereditario. 91
High pathological response rate in locally advanced esophageal cancer after neoadjuvant combined modality therapy: dose finding of a weekly chemotherapy schedule with protracted venous infusion of 5-fluorouracil and dose escalation of cisplatin, docetaxel and concurrent radiotherapy. 90
Cisplatin pharmacokinetics using a five-day schedule during repeated courses of chemotherapy in germ cell tumors 90
Fanconi's anaemia in adults: study of three families 89
Analisi immunoistochimica per la ricerca di micrometastasi osteo midollari nel carcinoma mammario. 88
Caratterizzazione di una nuova linea cellulare di melanoma umano. 86
A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis 85
Use of the ratio of time to progression following first and second line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma 85
La terapia ad alte dosi nel carcinoma mammario metastatico e nella mastite carcinomatosa. 85
Evoluzione del concetto di dose in chemioterapia: basi teoriche e modelli matematici. Cetto G.L., Molino A. in: “L’intensità di dose in Oncologia Medica”. G.Bonadonna, G.Robustelli della Cuna eds., Edimes, Progressi in Oncologia Clinica 4: pag. 11-22, Pavia 1995 85
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 85
Comparison of two different methods for the determination of estrogen receptors (ER) in breast cancer (b.c.). 83
Ricerca immunoistochimica di micrometastasi osteo midollari in 33 pazienti portatrici di carcinoma della mammella. 83
Anemia, cancro e chemioterapia antiblastica. 83
[Idiopathic aneurysm of the right ventricle. Report of a case] 82
Clinical evaluation of 51 patients with small cell lung cancer (SCLC). 82
The antiemetic activity of high dose metoclopramide and high dose alizapride in combination with lorazepam in patients receiving chemotherapy 81
Efficacy of chemotherapy in two cases of extranodal retroperitoneal germ cell tumors. 80
Ki-67 e risposta alla chemioterapia nel carcinoma mammario avanzato. 80
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer 79
Positive immunostaining with MLuC1 of bone marrow aspirate predicts poor outcome in patients with small-cell lung cancer 78
New standards in the chemotherapy of metastatic hormone-refractory prostate cancer 78
A good death for cancer patients:still a dream? 78
Gemcitabine and continuous infusion of 5-fluorouracil in locally advanced and metastatic pancreatic cancer: a phase I-II study 78
Leucemia linfatica acuta dopo radioterapia e chemioterapia adiuvante (CMF) per cr della mammella. 78
The detection of breast cancer (b.c.) cells in bone marrow (b.m.): comparative analysis of sensitivity and specificity of three different methods. 78
Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis 76
Ifosfamide encephalopathy: a case report 75
Correlazione tra trattamento adiuvante (chemioterapia e/o ormonoterapia), dosaggio RE e RPg, N , comparsa di metastasi in 150 pazienti con carcinoma mammario. 75
Economic aspect of high-dose-chemotherapy (HDC): a clinician’s perspective review 74
Detection of a soluble form of the receptor for interleukin 2 in the serum of patients with hairy cell leukaemia 73
Gemcitabine (GEM) and Vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): A phase II study in elderly or poor performance status patients 73
Neo-adjuvant chemotherapy in non-smallcell lung cancer (SSCLC) 72
Comparative analysis of three different methods in detecting breast cells in bone marrow. 72
Chemotherapy for metastatic melanoma 71
Cytofluorymetric evaluation of DNA ploidy in lung cancer: a broncoscopic study 71
Multicentric phase II trial of gemcitabine plus epirubucin plus paclitaxel as first-line chemotherapy in metastatic breast cancer. 70
Correlation of replicative fraction by Ki67 immunohistochemistry (RF) with clinico pathological features and prognosis in breast cancer (B.C.). 70
A phase II study of gemcitabine (GEM) and vindesine (VDS) in elderly or poor performance patients with unresectable non small cell lung cancer (NSCLC): final results. 70
Identification of Clinical Prognostic Factors in Patients with Unknown Primary Tumors Treated with a Platinum-Based Combination 69
Attività proliferativa del carcinoma mammario: studio su 329 pazienti. 69
Replicative fraction in breast carcinoma. An Immunohistochemical study of 236 cases. 68
Comparative analysis of three different techniques in detecting breast cancer (b.c.) cells in bone marrow (b.m.). 68
Micrometastasi midollari in pazienti con carcinoma mammario operabile: studio su 51 casi. 67
Comportamento del CA 15 3 nelle pazienti affette da carcinoma mammario (stadio I III). 67
Phase I°/II° trial of recombinant alfha 2 interferon (IFN) and Vinblastine (VBL) in metastatic renal cell cancer (MRCC). 67
Attività di un Registro Tumori di Patologia Mammaria su base ospedaliera. 67
Prognostic significance of estrogen and progesterone receptors (RE and PR) in 234 breast cancer patients. 67
Impact of a breast cancer registry on the management of breast cancer patients 66
Adjuvant chemotherapy with high dose epirubicin and cyclophosphamide (ec) vs cyclophosphamide, methotrexate, fluorouracil (CMF) in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial. E 66
Anemia, cancro e chemioterapia antiblastica. 65
Analisi puntiforme dei valori sierici del CA 15.3 e del CEA in pazienti con carcinoma della mammella. 65
Dosaggio della NSE in pazienti affetti da tumori di origine neuroectodermica. 65
Bone metastases from primary cardiac sarcoma: case report 65
Estramustine plus docetaxel as second-line therapy in patients with hormone-refractory prostate cancer resistant to docetaxel alone 65
Adjuvant chemotherapy with high-dose epirubicin and cyclophosphamide vs CMF in high-risk premenopausal breast cancer patients (pts). Prospective randomized phase III trial. 64
Bone marrow micrometastases in breast cancer patients. 64
The Gemcitabine/Epirubicin /Paclitaxel trials in advanced breast cancer 63
Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis. 63
Immunodetection of breast cancer cells in bone marrow for monitoring high-dose sequential chemotherapy 62
Correlations between family history and cancer characteristics in 2256 breast cancer patients. 62
Inductively coupled plasma mass spectroscopy (ICP-MS) quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin or carboplatin based chemotherapy 62
Caratterizzazione fenotipica di cloni ottenuti da una linea cellulare di melanoma umano. 62
Totale 8.667
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.454
article - articoli 16.873
book - libri 1.670
conference - conferenze 19.911
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.337 0 0 0 177 94 238 125 190 86 196 57 174
2020/20211.403 72 233 86 110 148 208 16 177 140 11 165 37
2021/20221.482 77 463 13 207 78 37 33 77 64 31 128 274
2022/20232.556 206 219 272 365 345 632 23 141 271 18 45 19
2023/20241.051 40 114 90 113 146 152 39 39 5 48 170 95
2024/2025557 182 216 97 62 0 0 0 0 0 0 0 0
Totale 11.690